Updated UK recommendations for HER2 assessment in breast cancer
(2014)
Journal Article
Rakha, E. A., Pinder, S. E., Bartlett, J. M., Ibrahim, M., Starczynski, J., Carder, P. J., …Ellis, I. O. (2015). Updated UK recommendations for HER2 assessment in breast cancer. Journal of Clinical Pathology, 68(2), 93-99. https://doi.org/10.1136/jclinpath-2014-202571
Human epidermal growth factor receptor 2 (HER2) overexpression is present in approximately 15% of early invasive breast cancers, and is an important predictive and prognostic marker. The substantial benefits achieved with anti-HER2 targeted therapies... Read More about Updated UK recommendations for HER2 assessment in breast cancer.